Biggest News Aggregation in the World
๐Ÿ“ฐ Week Study News

Week Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Week Study. Real-time updates on events, politics, business and more.

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

Study Achieves Primary and all Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight at all Doses as Compared to Placebo Up to 13.1% Placebo-Adjusted Mean Weight...
Drug Administration Ligand Pharmaceuticals Incorporated Therapeutics Inc Study Achieves Primary Secondary Endpoints Body Weight

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

13-Week Study to Evaluate the Safety and Efficacy of VK2735 Dosed Weekly Trial Size Increased from 125 to 176 Patients Due to Elevated Demand SAN DIEGO, Oct. 23, 2023 /PRNewswire/ -- Viking...
Ligand Pharmaceuticals Incorporated Therapeutics Inc Obesity Society Drug Administration Prnewswire Viking Therapeutics Inc Week Study

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science